1. Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity
   Shaikh M. Atif et al, 2018, American Journal of Respiratory Cell and Molecular Biology CrossRef
2. Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development
   Igor Visconte Gonçalves et al, 2024, Scientific Reports CrossRef
3. The role of B-1 cells in cancer progression and anti-tumor immunity
   Nely Rodríguez-Zhurbenko et al, 2024, Frontiers in Immunology CrossRef
4. Linking murine resistance to secondary cystic echinococcosis with antibody responses targeting Echinococcus granulosus tegumental antigens
   Sebastián Miles et al, 2020, Immunobiology CrossRef
5. Antitumoral and Antimetastatic Activity by Mixed Chelate Copper(II) Compounds (Casiopeínas®) on Triple-Negative Breast Cancer, In Vitro and In Vivo Models
   Mauricio M. González-Ballesteros et al, 2024, International Journal of Molecular Sciences CrossRef
6. Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention
   Camille Jacqueline et al, 2020, Seminars in Immunology CrossRef
7. The IgM as a tool for recognition of early tumoral antigens
   Pedro Ostoa-Saloma, 2021, Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives CrossRef
8. Drivers and regulators of humoral innate immune responses to infection and cancer
   Deepak Kumar et al, 2020, Molecular Immunology CrossRef